Yvonne Greenstreet, Chief Executive Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 15,230 shares at $195.65 ($3.0M) on 2023-04-27, disclosed to the SEC on 2023-04-28.
Open-market sale of $3.0M ALNY by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $193.18 | 628 | $121K | 4.1% |
| 2 | $193.18 | 628 | $121K | 4.1% |
| 3 | $193.93 | 2,898 | $562K | 19.0% |
| 4 | $193.93 | 2,898 | $562K | 19.0% |
| 5 | $194.94 | 3,225 | $629K | 21.2% |
| 6 | $194.94 | 3,225 |
| $629K |
| 21.2% |
| 7 | $195.65 | 331 | $65K | 2.2% |
| 8 | $195.65 | 331 | $65K | 2.2% |
| 9 | $197.08 | 533 | $105K | 3.5% |
| 10 | $197.08 | 533 | $105K | 3.5% |
| Total | $194.59 avg | 15,230 | $3.0M | 100% |
| Filing → |
| ALNY | SELL | 2026-02-17 | $2.2M | — | Filing → |
| ALNY | SELL | 2026-01-14 | $3.5M | — | Filing → |
| ALNY | SELL | 2025-11-14 | $23.2M | — | Filing → |